Clinical features of inflammatory bowel disease unclassified: a case-control study

被引:1
|
作者
Shao, Yupei [1 ]
Zhao, Yixiao [2 ]
Lv, Hong [1 ]
Yan, Pengguang [1 ]
Yang, Hong [1 ]
Li, Jingnan [1 ]
Li, Ji [1 ]
Qian, Jiaming [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gastroenterol, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
[2] Civil Aviat Gen Hosp, Dept Gastroenterol, Beijing 100025, Peoples R China
关键词
Inflammatory bowel disease; Inflammatory bowel disease unclassified; Indeterminate colitis; Clinical features; Prognosis; POUCH-ANAL ANASTOMOSIS; INDETERMINATE COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; RETROSPECTIVE MULTICENTER; DIFFERENTIATION; DIAGNOSIS; GRANULOMA; CONSENSUS; SPECTRUM;
D O I
10.1186/s12876-024-03171-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundApproximately 10-15% of inflammatory bowel disease (IBD) patients with overlapping features of ulcerative colitis (UC) and Crohn's disease (CD) are termed as inflammatory bowel disease unclassified (IBDU). This study aimed to describe the clinical features of IBDU and evaluate the potential associated factors of reclassification.MethodsThe clinical data of 37 IBDU patients were retrospectively analyzed from November 2012 to November 2020. 74 UC and 74 CD patients were randomly selected and age- and sex-matched with the 37 IBDU patients. Clinical characteristics were compared between the three patient groups. Potential factors associated with the IBDU reclassification were evaluated.Results60% of IBDU patients displayed rectal-sparing disease, and 70% of them displayed segmental disease. In comparison to UC and CD, the IBDU group demonstrated higher rates of gastrointestinal bleeding (32.4%), intestinal perforation (13.5%), spontaneous blood on endoscopy (51.4%), and progression (56.8%). The inflammation proceeded relatively slowly, manifesting as chronic alterations like pseudopolyps (78.4%) and haustra blunt or disappearance (56.8%). 60% of IBDU patients exhibited crypt abscess, and 16.7% of them exhibited fissuring ulcers or transmural lymphoid inflammation. The proportions of IBDU patients receiving immunosuppressants, surgery, and infliximab were basically the same as those of CD patients. During the 79 (66, 91) months of follow-up, 24.3% of IBDU patients were reclassified as UC, while 21.6% were reclassified as CD. The presence of intestinal hemorrhaging was associated with CD reclassification, while hypoalbuminemia was associated with UC reclassification.ConclusionsIBDU may evolve into UC or CD during follow-up, and hemorrhage was associated with CD reclassification. Different from the other two groups, IBDU exhibited a more acute onset and a gradual progression. When an IBD patient presents with transmural inflammation or crypt abscess but lacks transmural lymphoid aggregates or fissuring ulcers, the diagnosis of IBDU should be considered.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study
    Shao, Xiaona
    Yang, Lei
    Hu, Keyue
    Shen, Ruiwei
    Ye, Qunqun
    Yuan, Xiaogang
    Zhao, Qiang
    Shen, Jianwei
    [J]. MEDIATORS OF INFLAMMATION, 2020, 2020
  • [32] A CASE-CONTROL STUDY OF SMOKING IN INFLAMMATORY BOWEL-DISEASE COMPARED TO THE IRRITABLE BOWEL SYNDROME
    HANAUER, SB
    SILVERSTEIN, MD
    EVANS, AA
    KIRSNER, JB
    [J]. CLINICAL RESEARCH, 1984, 32 (02): : A223 - A223
  • [33] Preclinical Markers in Inflammatory Bowel Disease. A Nested Case-Control Study
    Lundgren, David
    Widbom, Lovisa
    Hultdin, Johan
    Karling, Pontus
    [J]. CROHNS & COLITIS 360, 2021, 3 (04)
  • [34] Is colon cancer susceptibility in inflammatory bowel disease inherited? A case-control study
    Chung-Faye, G
    Manjunath, S
    Mohammed, I
    Boulton, R
    Jankowski, J
    Allan, RN
    [J]. GUT, 2000, 46 : A6 - A6
  • [35] Thromboembolism in inflammatory bowel disease - Preliminary results of a case-control study.
    Novacek, G
    Miehsler, W
    Valic, E
    Tillinger, W
    Reinisch, W
    Feichtenschlager, T
    Linsbichler, S
    Konnaris, C
    Wolf, C
    Vogelsang, H
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1361 - A1361
  • [36] Risk Factors for Lymphoma in Patients with Inflammatory Bowel Disease: A Case-control Study
    Afif, Waqqas
    Sandborn, William J.
    Faubion, William A.
    Rahman, Meher
    Harmsen, Scott W.
    Zinsmeister, Alan R.
    Loftus, Edward V., Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1384 - 1389
  • [37] Residential mobility and childhood inflammatory bowel disease: a nationwide case-control study
    Alimam, Wafa
    Nikkila, Atte
    Raitanen, Jani
    Kolho, Kaija-Leena
    Auvinen, Anssi
    [J]. ANNALS OF EPIDEMIOLOGY, 2023, 80 : 53 - 61
  • [38] Is occupation a risk factor for developing Inflammatory Bowel Disease? A case-control study
    Barreiro, M. V. Mauriz
    Ruano-Ravina, A.
    Ferreiro-Iglesias, R.
    Baston-Rey, I.
    Porto-Silva, S.
    Nieto-Garcia, L.
    Martinez-Seara, X.
    Martin-Gisbert, L.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 998 - 998
  • [39] A Case-Control study of the prevalence of neurological diseases in inflammatory bowel disease (IBD)
    Aquino Gondim, Francisco de Assis
    de Oliveira, Gisele Ramos
    Teles, Benedito Cadorno V.
    Souza, Marcellus H. L. P.
    Braga, Lucia L. B. C.
    Messias, Erick L.
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2015, 73 (02) : 119 - 124
  • [40] Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study
    Losurdo, Giuseppe
    La Fortezza, Rosa Federica
    Iannone, Andrea
    Contaldo, Antonella
    Barone, Michele
    Ierardi, Enzo
    Di Leo, Alfredo
    Principi, Mariabeatrice
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (47) : 7528 - 7537